V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160014797 | 160012750 | 1.74 | 73.8 | Neo-adjuvant (N) | 2018-11-27 | 2018-12-04 | Liposomal Doxorubicin 40mg/m2 | 02 | N | LIPOSOMAL DOXORUBICIN | 100168691 |
| 160014798 | 160012751 | 1.56 | 92.2 | null | 2018-12-01 | 2018-12-01 | Doxorubicin + Olaratumab | 02 | null | DOXORUBICIN + OLARATUMAB | 101328497 |
| 160014802 | 160012752 | 1.76 | 93.6 | null | 2020-03-07 | 2020-03-21 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 100366365 |
| 160014805 | 160012753 | 1.84 | 94.7 | Neo-adjuvant (N) | 2020-12-17 | 2021-01-05 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101441226 |
| 160014807 | 160012754 | 1.9 | 69.8 | Palliative (P) | 2019-12-13 | 2019-12-17 | Bevacizumab | 02 | N | DOXORUBICIN + OLARATUMAB | 100724141 |
| 160014808 | 160012755 | 1.61 | 84.7 | null | 2019-07-18 | 2019-07-22 | Bevacizumab 15mg/kg | 02 | null | BEVACIZUMAB | 100916509 |
| 160014811 | 160012756 | 1.44 | 77.5 | Palliative (P) | 2020-07-14 | 2020-08-05 | GEMCARBO | 02 | N | CARBOPLATIN + GEMCITABINE | 100126276 |
| 160014812 | 160012757 | 1.6 | 75.1 | Palliative (P) | 2018-12-12 | 2019-01-03 | Docetaxel + Gemcitabine with GCSF | 02 | N | DOCETAXEL + GEMCITABINE | 101659167 |
| 160014815 | 160012758 | 0.02 | 59 | null | 2020-12-17 | 2021-01-10 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 100340818 |
| 160014816 | 160012759 | 1.73 | 64.8 | Disease modification (D) | null | 2020-07-14 | Liposomal Doxorubicin (Caelyx) | N | Y | LIPOSOMAL DOXORUBICIN | 100241575 |
| 160014818 | 160012760 | 1.74 | 58.6 | Palliative (P) | 2017-07-24 | 2017-08-07 | Bevacizumab | 02 | N | CARBOPLATIN | 100979121 |
| 160014821 | 160012761 | 1.77 | 93.1 | Palliative (P) | 2017-08-28 | 2017-09-05 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN + GEMCITABINE | 101055623 |
| 160014823 | 160012762 | 1.51 | 91.55 | Palliative (P) | 2019-07-05 | 2019-07-21 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100298661 |
| 160014827 | 160012763 | 1.39 | 59.9 | 03 | 2016-08-26 | 2016-10-10 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 100715484 |
| 160014828 | 160012764 | 1.74 | 66.6 | Palliative (P) | 2016-06-20 | 2016-07-06 | Bevacizumab | null | N | CARBOPLATIN + GEMCITABINE | 100193688 |
| 160014840 | 160012765 | 1.68 | 83 | Palliative (P) | 2019-03-02 | 2019-03-15 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100428462 |
| 160014841 | 160012766 | 1.69 | 78.2 | Palliative (P) | 2017-10-11 | 2018-01-25 | Bevacizumab 15mg/kg | 02 | N | PACLITAXEL | 100768747 |
| 160014845 | 160012767 | 1.67 | 77.9 | Palliative (P) | 2018-10-23 | 2019-05-30 | Bevacizumab 7.5mg/kg | 02 | N | CISPLATIN + PEMETREXED | 100169298 |
| 160014846 | 160012768 | 1.57 | 78.5 | Neo-adjuvant (N) | 2016-10-07 | 2017-05-21 | Doxorubicin + Olaratumab | 02 | N | DOXORUBICIN + OLARATUMAB | 101634126 |
| 160014850 | 160012769 | 1.65 | 45.8 | Neo-adjuvant (N) | 2021-02-07 | 2021-02-10 | Liposomal Doxorubicin 50mg/m2 | N | N | LIPOSOMAL DOXORUBICIN | 101313616 |
| 160014851 | 160012770 | 1.72 | 88.7 | Palliative (P) | 2017-12-09 | 2017-12-22 | DOCETAXEL + GEMCITABINE | 02 | N | DOCETAXEL + GEMCITABINE | 101703111 |
| 160014854 | 160012771 | 1.74 | 84.45 | Neo-adjuvant (N) | 2017-12-24 | 2018-07-30 | Bevacizumab 7.5mg/kg | 02 | N | DOCETAXEL + GEMCITABINE | 100565074 |
| 160014855 | 160012772 | 1.53 | 74.7 | Palliative (P) | 2020-05-11 | 2020-05-13 | Bevacizumab | 02 | N | CISPLATIN + PEMETREXED | 101496455 |
| 160014858 | 160012773 | 1.69 | 93.6 | 03 | null | 2019-12-07 | DOCETAXEL + GEMCITABINE | 02 | N | DOCETAXEL + GEMCITABINE | 100317216 |
| 160014859 | 160012774 | 1.69 | 92.2 | 03 | 2019-06-20 | 2019-06-21 | PACLITAXEL | 02 | N | PACLITAXEL | 101378710 |
| 160014860 | 160012775 | 1.54 | 69 | Palliative (P) | 2017-03-31 | 2017-04-13 | Bevacizumab | 2 | N | CARBOPLATIN | 101077483 |
| 160014862 | 160012776 | 1.84 | 66.2 | Palliative (P) | 2019-07-21 | 2019-09-15 | Bevacizumab 7.5mg/kg | N | N | CARBOPLATIN + GEMCITABINE | 100109386 |
| 160014866 | 160012777 | 1.63 | 68.9 | Palliative (P) | 2020-04-28 | 2020-05-15 | Bevacizumab | 02 | N | CARBOPLATIN + GEMCITABINE | 100101936 |
| 160014867 | 160012778 | 1.93 | 61.2 | Palliative (P) | 2019-04-28 | 2019-12-30 | Carboplatin AUC 2 - 5 | N | N | CARBOPLATIN | 101225189 |
| 160014869 | 160012779 | 1.74 | 54.8 | Palliative (P) | 2017-07-12 | 2017-07-14 | Bevacizumab | 02 | N | BEVACIZUMAB | 101443326 |
| 160014878 | 160012780 | 1.59 | 71.3 | null | 2019-09-01 | 2019-09-16 | Bevacizumab 7.5mg/kg | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100653598 |
| 160014879 | 160012781 | 1.68 | 72.5 | Palliative (P) | 2018-08-19 | 2018-10-27 | Doxorubicin + Olaratumab | 02 | N | DOXORUBICIN + OLARATUMAB | 100761287 |
| 160014889 | 160012782 | 1.64 | 72.5 | Palliative (P) | 2019-01-21 | 2019-01-26 | Bevacizumab 7.5mg/kg | N | N | CISPLATIN + PEMETREXED | 101311602 |
| 160014891 | 160012783 | 1.56 | 70 | Palliative (P) | 2017-04-18 | 2017-05-05 | DOCETAXEL + GEMCITABINE | 02 | N | DOCETAXEL + GEMCITABINE | 101812067 |
| 160014897 | 160012784 | 1.72 | 109.5 | Palliative (P) | 2016-04-11 | 2016-04-12 | PACLITAXEL | 02 | N | PACLITAXEL | 101459950 |
| 160014901 | 160012785 | 1.8 | 59.5 | null | 2016-07-02 | 2016-07-10 | Docetaxel+Gemcitabine (no prior RT) | 02 | null | DOCETAXEL + GEMCITABINE | 100914478 |
| 160014905 | 160012786 | 1.53 | 80 | Palliative (P) | 2021-02-04 | 2021-02-09 | Docetaxel + Gemcitabine (prior RT) | 02 | N | DOCETAXEL + GEMCITABINE | 100660134 |
| 160014906 | 160012787 | 1.54 | 71.6 | null | 2019-08-19 | 2020-01-08 | Bevacizumab 7.5mg/kg | null | null | DOCETAXEL + GEMCITABINE | 101366873 |
| 160014912 | 160012788 | 1.83 | 76 | null | 2019-03-28 | 2019-04-02 | CARBOPLATIN + PACLITAXEL | 2 | null | LIPOSOMAL DOXORUBICIN | 100678496 |
| 160014917 | 160012789 | 1.65 | 83.6 | null | 2019-01-15 | 2019-03-06 | Doxorubicin + Olaratumab | 02 | null | DOXORUBICIN + OLARATUMAB | 101635913 |
| 160014921 | 160012790 | 1.67 | 79.1 | Palliative (P) | 2019-11-06 | 2019-11-21 | Bevacizumab | 02 | N | PACLITAXEL | 100894640 |
| 160014924 | 160012791 | 1.5 | 119 | Neo-adjuvant (N) | 2020-10-08 | 2020-10-25 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 100296702 |
| 160014928 | 160012792 | 1.73 | 72.5 | Palliative (P) | 2019-02-01 | 2019-02-02 | Bevacizumab | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101050204 |
| 160014930 | 160012793 | 1.66 | 84 | Palliative (P) | 2019-03-17 | 2019-05-12 | Doxorubicin + Olaratumab | 02 | N | DOXORUBICIN + OLARATUMAB | 101121298 |
| 160014932 | 160012794 | null | 74.6 | Palliative (P) | 2019-05-05 | 2019-05-23 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | PACLITAXEL | 100139141 |
| 160014934 | 160012795 | 1.8 | 65.8 | null | 2018-10-03 | 2018-10-06 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 100201377 |
| 160014936 | 160012796 | 1.71 | 77.2 | Palliative (P) | 2016-02-07 | 2016-06-03 | Bevacizumab 7.5mg/kg | 02 | null | CARBOPLATIN | 100734876 |
| 160014938 | 160012797 | 1.69 | 76.9 | Neo-adjuvant (N) | 2019-04-16 | 2019-04-17 | Liposomal Doxorubicin (Caelyx) | 02 | N | LIPOSOMAL DOXORUBICIN | 101468234 |
| 160014939 | 160012798 | 1.64 | 89 | Palliative (P) | 2019-10-30 | 2019-11-02 | Bevacizumab 7.5mg/kg | 02 | N | CISPLATIN + PEMETREXED | 100143832 |
| 160014940 | 160012799 | 1.74 | 90 | Adjuvant (A) | 2018-02-26 | 2018-03-13 | Paclitaxel (2 or 3 weekly) | 02 | null | PACLITAXEL | 101064435 |